11/21/2019  5:39:50 PM Chg. - Volume Bid7:15:06 AM Ask7:15:13 AM Market Capitalization Dividend Y. P/E Ratio
23.960EUR - 863,064
Turnover: 20.57 mill.
23.960Bid Size: 40 23.960Ask Size: 62 10.6 bill.EUR 2.34% 31.53

Business description

Bureau Veritas is a world-leading provider in testing, inspection and certification. Created in 1828, the Group has more than 76,000 employees in around 1,400 offices and laboratories all across the world. Bureau Veritas helps its clients to improve their performance by offering services and innovative solutions in order to ensure that their assets, products, infrastructure and processes meet standards and regulations in terms of quality, health and safety, environmental protection and social responsibility.
 

Management board & Supervisory board

CEO
Didier Michaud-Daniel
Management board
Francois Chabas, Eduardo Camargo, Helen Bradley, Jacques Pommeraud, Juliano Cardoso, Laurent Louail, Matthieu de Tugny, Natalia Shuman, Oliver Butler
Supervisory board
Aldo Cardoso, Ana Giros Calpe, André François-Poncet, Claude Ehlinger, Frédéric Sanchez, Ieda Gomes Yell, Lucia Sinapi-Thomas, Pascal Lebard, Philippe Lazare, Siân Herbert-Jones, Stéphane Bacquaert, Stéphanie Besnier
 

Company data

Name: Bureau Veritas SA
Address: 67-71 Boulevard du Château,F-92200 Neuilly-sur-Seine
Phone: +33-1-5524-7000
Fax: +33-1-5524-7032
E-mail: -
Internet: finance.bureauveritas.com
Industry: Consumer Goods
Sector: Consumer services
Sub sector: Consumer services
End of financial year: 12/31
Free Float: 61.90%
IPO date: -

Investor relations

Name: Laurent Brunelle
IR phone: +33-1-5524-7609
IR Fax: -
IR e-mail: laurent.brunelle@bur...tas.com laurent.brunelle@bureauveritas.com

Company calendar

CW 9 | 2/27/2020 4th Quarter/Annual Report
CW 17 | 4/23/2020 Interim Report 1st Quarter/3 Months
CW 20 | 5/14/2020 General Shareholder Meeting
CW 31 | 7/28/2020 Interim Report 2nd Quarter/6 Months
CW 43 | 10/22/2020 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Freefloat
 
61.90%
Wendel group
 
35.30%
eigene Aktien
 
1.40%
Mitarbeiter
 
1.40%